TRIPS Agreement

eugene-chystiakov-YGCVdvX4zjg-unsplash

The EU’s Quad Agreement on COVID-19 Vaccines Is Too Little, Too Late

Anubha Sinha 29/03/2022

In practical terms, we need to see how much...

health-aids-safrica

Marking World AIDS Day, Campaigners Warn ‘History Is Repeating Itself With COVID’

Jake Johnson 02/12/2021

'This is a story about how corporate greed and...

Paris street sweeper Ludovic Franceschet aka Ludovic_off who became a TikTok celebrity

COVID-19: Who Is the ‘Public’ in IP Law That Defines Its Public Purpose?

Hyo Yoon Kang 07/03/2021

The entangled issue of public vaccine subsidy, ensuing distribution...

Bt cotton, Monsanto, Nuziveedu Seeds, Bacillus thuringiensis, Bt toxins, transgene, PPVFR Act, Patents Act 1970, sui generis, TRIPS Agreement, bollworm, patentability,

Supreme Court’s Monsanto Ruling Overlooks Need to Protect Farmers’ Rights

Kumar Karan and Mehak Sachdeva 11/01/2019

By allowing Monsanto its patent under the Patents Act...

Monsanto, bollworm pest, Bt cotton, TRIPS Agreement, plant breeding, agritech, Supreme Court of India, Delhi high court, crop biotechnology, Nuziveedu, Indian seed companies, Cry2Ab gene, Helicoverpa armigera, Bacillus thuringiensis, GM mustard, Bt brinjal, PPVFR Act 2001, Patents Act 1970s, Rohinton Nariman,

Backgrounder: The Laws Surrounding Monsanto’s Claim to the Bt Cotton Patent

Kumar Karan and Mehak Sachdeva 08/01/2019

How can a company own a patent over genetically...

generic-medicines

New Government Report Affirms India’s Patient-First Commitment on Pharma Patents

Anoo Bhuyan 07/03/2018

A government review says it is well within its...

2509235914_e2619447bf_b

RCEP and Health: This Kind of ‘Progress’ is Not What India and the World Need

Shiba Phurailatpam and Kajal Bhardwaj 27/02/2017

Concerns remain over the impact of RCEP negotiations on...